BPC-157, NAD, and the Truth the Wellness Industry Isn't Telling | Dr. Rachele Pojednic

BPC-157, NAD, and the Truth the Wellness Industry Isn't Telling | Dr. Rachele Pojednic

June 8, 2026 · 55 min

About this episode

Dr. Rachele Pojednic discusses the realities of peptides and NAD in women's wellness, highlighting risks and misconceptions in the wellness industry.

In this episode, we sit down with Dr. Rachele Pojednic, PhD, Chief Science Officer at Restore Hyper Wellness and faculty at Stanford Lifestyle Medicine, to cut through the noise on one of the most talked-about topics in women’s wellness: peptides and NAD. Dr. Pojednic pulls back the curtain on what peptides actually are, why most of the ones being sold online right now have almost no human data behind them, and the very real risks of buying from the gray market. She also explains why NAD IV drips are largely a waste of money (and sometimes genuinely miserable), what the research actually supports for longevity, and why BPC-157 sits at the top of her study list. The conversation ends with a grounding reminder that none of these therapies will move the needle if the foundational behaviors are not already in place. WHAT WE EXPLORE * What peptides actually are and why GLP-1 drugs are technically peptides * BPC-157, growth hormone secretagogues, and the peptides women are hearing about most * Why almost no human clinical data exists for the peptides flooding the wellness market right now * The gray market problem: what you are really buying when you order peptides online * Why NAD IV…

Topics covered

More episodes of Proof of Practice Podcast

Explore listener stats, chart rankings, contacts and more on the Proof of Practice Podcast podcast page.